drugset / Trial / NCT00152503
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial will evaluate the efficacy and safety of UCB44212 as add-on therapy in subjects with focal epilepsy.
Timeline
- Start
- 2005-08-31
- Primary completion
- 2006-05-12
- Completion
- 2006-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seletracetam | Small molecule | 10 mg | Oral |
| Subject | Seletracetam | Small molecule | 20 mg | Oral |
| Subject | Seletracetam | Small molecule | 40 mg | Oral |
| Subject | Seletracetam | Small molecule | 80 mg | Oral |